| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/1999 | US5948901 Antisense oligonucleotides for aromatase inhibition |
| 09/07/1999 | US5948898 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression |
| 09/07/1999 | US5948896 Processes for preparing 13-deoxy anthracycline derivatives |
| 09/07/1999 | US5948884 Cyclic peptide with substituents on the methylene group of sarcosine in position 3 of cyclosporin; viricide against human immunodeficiency virus without immunosuppressive effect |
| 09/07/1999 | US5948824 Use of a chemical agent for reducing the changes in waistline and the effect of constipation due to the taking of other agents |
| 09/07/1999 | US5948823 Irradiation protection method |
| 09/07/1999 | US5948822 Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
| 09/07/1999 | US5948821 Methods of using ajoene |
| 09/07/1999 | US5948818 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
| 09/07/1999 | US5948815 Using genistein |
| 09/07/1999 | US5948814 Genistein for the treatment of cystic fibrosis |
| 09/07/1999 | US5948813 Method of preventing allograft rejection |
| 09/07/1999 | US5948811 Psychological disorders; parkinson's disease |
| 09/07/1999 | US5948810 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948806 Treatment of Parkinson's disease with (+)2-(ethyl-2,3-dihydrobenzofuranyl)-2-Imidazoline (dexefaroxan or (+) efaroxan) |
| 09/07/1999 | US5948804 Anaesthetic premedication |
| 09/07/1999 | US5948803 Improve the insulin resistance and have potent hypoglycemic effect and lipid-lowering effect |
| 09/07/1999 | US5948802 Stroke, anticonvulsants, antiepilepic agents, antiasthma agents, migraines, nervous system disorders, sexual disorders, incotinence |
| 09/07/1999 | US5948801 Treatment of retinal edema with brinzolamide |
| 09/07/1999 | US5948800 Preventive or therapeutic drug for Alzheimer's disease |
| 09/07/1999 | US5948799 Method for improving morbidity and/or mortality |
| 09/07/1999 | US5948796 Benzo B!thiophene compounds, intermediates, formulations, and methods |
| 09/07/1999 | US5948795 Benzothiopene compounds, and uses and formulations thereof |
| 09/07/1999 | US5948794 Enterokinetic benzamide |
| 09/07/1999 | US5948791 Quinoline derivatives for treating malaria |
| 09/07/1999 | US5948790 Retroviral protease inhibitors |
| 09/07/1999 | US5948789 Process for synthesis of substituted sulphoxides |
| 09/07/1999 | US5948788 Normorphine and normorphinone derivatives |
| 09/07/1999 | US5948787 Mixture of morphine sulfate and surfactant |
| 09/07/1999 | US5948786 Blocking tumor necrosis factor |
| 09/07/1999 | US5948784 Nephritis |
| 09/07/1999 | US5948782 Antiinflammatory agent; rheumatic diseases |
| 09/07/1999 | US5948781 Adamantyl substituted oxindoles as pharmaceutical agents |
| 09/07/1999 | US5948780 Administering a metalloproteinase inhibitor |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948776 Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or ?linker? defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 ang. |
| 09/07/1999 | US5948773 Formulation comprising antibacterial substance and antiulcer substance |
| 09/07/1999 | US5948772 Useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass. |
| 09/07/1999 | US5948771 Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
| 09/07/1999 | US5948769 Orally administering to a mammal in need thereof a composition comprising 80 to 800 mg vitamin e, an effective amount of salicylic acid ester, and a pharmaceutically acceptable carrier or adjuvant. |
| 09/07/1999 | US5948768 Treatment of otitis media by sublingual administration of DNA |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948766 Use of tasteless, hydrolyzed collagen and agent containing the same |
| 09/07/1999 | US5948762 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor |
| 09/07/1999 | US5948675 Host-vector system which can be used in gene therapy |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor |
| 09/07/1999 | US5948626 Method of detecting human phospholipase inhibitor |
| 09/07/1999 | US5948440 Modified release matrix formulation of cefaclor and cephalexin |
| 09/07/1999 | US5948437 Pharmaceutical compositions using thiazepine |
| 09/07/1999 | US5948436 Protease inhibitor |
| 09/07/1999 | US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 09/07/1999 | US5948428 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 09/07/1999 | US5948422 Oral dosage-forms containing a β-lactam antibiotic |
| 09/07/1999 | US5948418 Mercaptans |
| 09/07/1999 | US5948405 Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity |
| 09/07/1999 | US5948401 Cationic therapeutic systems |
| 09/07/1999 | US5948390 Hydrated zinc cations; fully or partially protonated citrate moieties; cetyl pyridinium cations; and orally acceptable vehicle |
| 09/07/1999 | CA2168563C Benzopyrans and pharmaceutical compositions containing them |
| 09/07/1999 | CA2167257C Use of sertraline to treat cancer patients |
| 09/07/1999 | CA2148780C Use of active principles protected against rumen degradation as hepatoprotectors |
| 09/07/1999 | CA2147881C Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/07/1999 | CA2136042C 3-(7'-oxo-1'-aza-4'-oxabicyclo¬3.2.0| hept-3'-yl) propionic acid derivative |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2046313C Platinum (ii) complex and agent for treating malignant tumor |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/07/1999 | CA2014884C 5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of aids |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/07/1999 | CA2006119C Anti-aids viral agents and anticancer action |
| 09/07/1999 | CA2004166C Implant for use in bone surgery |
| 09/07/1999 | CA1340722C Pharmaceutical composition for the treatment of high blood pressure |
| 09/07/1999 | CA1340721C 1,4-dihydro-quinoline-and naphthyridine-3-carboxylic acid antibacterial agents |
| 09/05/1999 | CA2264431A1 Canine factor viii gene, protein and methods of use |
| 09/05/1999 | CA2261543A1 Anti-cellulite pantyhose |
| 09/04/1999 | CA2231080A1 Concentrated solutions of a 1,3,5-triazine derivative sunscreen and their use for the preparation of cosmetic compositions |
| 09/04/1999 | CA2231079A1 Sun protecting cosmetic compositions comprising derivatives of dibenzoylmethane, of benzophenone and of triazine |
| 09/04/1999 | CA2231005A1 Cyclin dependent kinase inhibitor |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | WO1999043698A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043691A1 2'-fluoronucleosides |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043678A1 Remedies/preventives for parkinson's disease |
| 09/02/1999 | WO1999043677A1 SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PYRIDAZINE |
| 09/02/1999 | WO1999043676A2 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| 09/02/1999 | WO1999043675A1 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043671A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials |
| 09/02/1999 | WO1999043670A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 09/02/1999 | WO1999043665A1 Process for the preparation of simvastatin and derivatives thereof |
| 09/02/1999 | WO1999043664A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999043661A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |